{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:39:44Z","timestamp":1794937184062,"version":"4.9.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1038\/ncpendmet0396","type":"journal-article","created":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T12:44:32Z","timestamp":1169469872000},"page":"92-102","source":"Crossref","is-referenced-by-count":532,"title":["Pheochromocytoma: recommendations for clinical practice from the First International Symposium"],"prefix":"10.1038","volume":"3","author":[{"given":"Karel","family":"Pacak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Ahlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"McNicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S","family":"Tischler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpendmet0396_CR1","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1056\/NEJM197909273011302","volume":"301","author":"EL Bravo","year":"1979","unstructured":"Bravo EL et al. (1979) Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med 301: 682\u2013686","journal-title":"N Engl J Med"},{"key":"BFncpendmet0396_CR2","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/clinchem\/37.10.1854","volume":"37","author":"TG Rosano","year":"1991","unstructured":"Rosano TG et al. (1991) Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma. Clin Chem 37: 1854\u20131867","journal-title":"Clin Chem"},{"key":"BFncpendmet0396_CR3","first-page":"319","volume":"23","author":"WF Young Jr","year":"1997","unstructured":"Young WF Jr (1997) Pheochromocytoma: issues in diagnosis & treatment. Compr Ther 23: 319\u2013326","journal-title":"Compr Ther"},{"key":"BFncpendmet0396_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12022-003-0012-4","volume":"14","author":"G Eisenhofer","year":"2003","unstructured":"Eisenhofer G et al. (2003) Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor. Endocr Pathol 14: 193\u2013212","journal-title":"Endocr Pathol"},{"key":"BFncpendmet0396_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/00004872-200106000-00006","volume":"19","author":"V Gardet","year":"2001","unstructured":"Gardet V et al. (2001) Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma. J Hypertens 19: 1029\u20131035","journal-title":"J Hypertens"},{"key":"BFncpendmet0396_CR6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/clinchem\/40.2.250","volume":"40","author":"E Gerlo","year":"1994","unstructured":"Gerlo E and Sevens C (1994) Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases. Clin Chem 40: 250\u2013256","journal-title":"Clin Chem"},{"key":"BFncpendmet0396_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/01.sla.0000193833.51108.24","volume":"243","author":"U Guller","year":"2006","unstructured":"Guller U et al. (2006) Detecting pheochromocytoma: defining the most sensitive test. Ann Surg 243: 102\u2013107","journal-title":"Ann Surg"},{"key":"BFncpendmet0396_CR8","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","volume":"287","author":"JW Lenders","year":"2002","unstructured":"Lenders JW et al. (2002) Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287: 1427\u20131434","journal-title":"JAMA"},{"key":"BFncpendmet0396_CR9","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/archinte.160.19.2957","volume":"160","author":"W Raber","year":"2000","unstructured":"Raber W et al. (2000) Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med 160: 2957\u20132963","journal-title":"Arch Intern Med"},{"key":"BFncpendmet0396_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1210\/jc.2002-021251","volume":"88","author":"AM Sawka","year":"2003","unstructured":"Sawka AM et al. (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88: 553\u2013558","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0396_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/eje.1.02097","volume":"154","author":"N Unger","year":"2006","unstructured":"Unger N et al. (2006) Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol 154: 409\u2013417","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet0396_CR12","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1210\/jc.2002-030005","volume":"88","author":"G Eisenhofer","year":"2003","unstructured":"Eisenhofer G et al. (2003) Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab 88: 2656\u20132666","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0396_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1442-2042.1999.06310.x","volume":"6","author":"N Furuta","year":"1999","unstructured":"Furuta N et al. (1999) Diagnosis of pheochromocytoma using [123I]- compared with [131I]-metaiodobenzylguanidine scintigraphy. Int J Urol 6: 119\u2013124","journal-title":"Int J Urol"},{"key":"BFncpendmet0396_CR14","first-page":"685","volume":"86","author":"E van der Harst","year":"2001","unstructured":"van der Harst E et al. (2001) [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab 86: 685\u2013693","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0396_CR15","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s002689900139","volume":"20","author":"DS O'Riordain","year":"1996","unstructured":"O'Riordain DS et al. (1996) Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg 20: 916\u2013921","journal-title":"World J Surg"},{"key":"BFncpendmet0396_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1148\/radiol.2222010622","volume":"222","author":"S Hoegerle","year":"2002","unstructured":"Hoegerle S et al. (2002) Pheochromocytomas: detection with 18F DOPA whole body PET\u2014initial results. Radiology 222: 507\u2013512","journal-title":"Radiology"},{"key":"BFncpendmet0396_CR17","unstructured":"Ilias I et al. (2002) 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the evaluation of patients with pheochromocytoma. Abstract P3-511. Presented at the 84th Annual Meeting of the Endocrine Society: 2002 June 19\u201322; San Fransisco, CA"},{"key":"BFncpendmet0396_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1245\/ASO.2006.04.022","volume":"13","author":"GN Mann","year":"2006","unstructured":"Mann GN et al. (2006) [(11)C]metahydroxyephedrine and [(18)f]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma. Ann Surg Oncol 13: 187\u2013197","journal-title":"Ann Surg Oncol"},{"key":"BFncpendmet0396_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/01.HYP.38.1.6","volume":"38","author":"K Pacak","year":"2001","unstructured":"Pacak K et al. (2001) 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38: 6\u20138","journal-title":"Hypertension"},{"key":"BFncpendmet0396_CR20","first-page":"1125","volume":"33","author":"B Shulkin","year":"1992","unstructured":"Shulkin B et al. (1992) PET scanning with hydroxyephedrine: A new approach to the localization of pheochromocytoma. J Nucl Med 33: 1125\u20131131","journal-title":"J Nucl Med"},{"key":"BFncpendmet0396_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1148\/radiol.2302021678","volume":"230","author":"C Trampal","year":"2004","unstructured":"Trampal C et al. (2004) Pheochromocytomas: detection with 11C hydroxyephedrine PET. Radiology 230: 423\u2013428","journal-title":"Radiology"},{"key":"BFncpendmet0396_CR22","first-page":"35","volume":"212","author":"BL Shulkin","year":"1999","unstructured":"Shulkin BL et al. (1999) Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy-D-glucose PET. Nucl Med 212: 35\u201341","journal-title":"Nucl Med"},{"key":"BFncpendmet0396_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1210\/jc.2003-031091","volume":"89","author":"I Ilias","year":"2004","unstructured":"Ilias I and Pacak K (2004) Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89: 479\u2013491","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0396_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/01.mnm.0000189780.54658.e8","volume":"27","author":"M Mamede","year":"2006","unstructured":"Mamede M et al. (2006) Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [123I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites. Nucl Med Commun 27: 31\u201336","journal-title":"Nucl Med Commun"},{"key":"BFncpendmet0396_CR25","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0140-6736(00)04378-6","volume":"357","author":"D Astuti","year":"2001","unstructured":"Astuti D et al. (2001) Germline SDHD mutation in familial phaeochromocytoma. Lancet 357: 1181\u20131182","journal-title":"Lancet"},{"key":"BFncpendmet0396_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/321282","volume":"69","author":"D Astuti","year":"2001","unstructured":"Astuti D et al. (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69: 49\u201354","journal-title":"Am J Hum Genet"},{"key":"BFncpendmet0396_CR27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal BE et al. (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848\u2013851","journal-title":"Science"},{"key":"BFncpendmet0396_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/jmg.39.3.178","volume":"39","author":"BE Baysal","year":"2002","unstructured":"Baysal BE et al. (2002) Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 39: 178\u2013183","journal-title":"J Med Genet"},{"key":"BFncpendmet0396_CR29","first-page":"5615","volume":"63","author":"AP Gimenez-Roqueplo","year":"2003","unstructured":"Gimenez-Roqueplo AP et al. (2003) Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Res 63: 5615\u20135621","journal-title":"Cancer Res"},{"key":"BFncpendmet0396_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/jmg.28.7.443","volume":"28","author":"ER Maher","year":"1991","unstructured":"Maher ER et al. (1991) Von Hippel-Lindau disease: a genetic study. J Med Genet 28: 443\u2013447","journal-title":"J Med Genet"},{"key":"BFncpendmet0396_CR31","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HPH Neumann","year":"2002","unstructured":"Neumann HPH et al. (2002) Germ-line mutations in nonsyndromic pheochromocytoma. New Engl J Med 346: 1459\u20131466","journal-title":"New Engl J Med"},{"key":"BFncpendmet0396_CR32","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/jnci\/djg024","volume":"95","author":"J Bryant","year":"2003","unstructured":"Bryant J et al. (2003) Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95: 1196\u20131204","journal-title":"J Natl Cancer Inst"},{"key":"BFncpendmet0396_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJM198802253180804","volume":"318","author":"RF Gagel","year":"1988","unstructured":"Gagel RF et al. (1988) The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. N Engl J Med 318: 478\u2013484","journal-title":"N Engl J Med"},{"key":"BFncpendmet0396_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan LM et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458\u2013460","journal-title":"Nature"},{"key":"BFncpendmet0396_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/gcc.2870130303","volume":"13","author":"MA Zeiger","year":"1995","unstructured":"Zeiger MA et al. (1995) Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma. Genes Chromosomes Cancer 13: 151\u2013156","journal-title":"Genes Chromosomes Cancer"},{"key":"BFncpendmet0396_CR36","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1210\/jc.2005-2178","volume":"91","author":"C Jimenez","year":"2006","unstructured":"Jimenez C et al. (2006) Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab 91: 2851\u20132858","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0396_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/jso.20177","volume":"89","author":"EE Elder","year":"2005","unstructured":"Elder EE et al. (2005) Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 89: 193\u2013201","journal-title":"J Surg Oncol"},{"key":"BFncpendmet0396_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW et al. (2005) Phaeochromocytoma. Lancet 366: 665\u2013675","journal-title":"Lancet"},{"key":"BFncpendmet0396_CR39","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HP Neumann","year":"2002","unstructured":"Neumann HP et al. (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346: 1459\u20131466","journal-title":"N Engl J Med"},{"key":"BFncpendmet0396_CR40","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"Amar L et al. (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23: 8812\u20138818","journal-title":"J Clin Oncol"},{"key":"BFncpendmet0396_CR41","first-page":"790","volume":"91","author":"DE Benn","year":"2005","unstructured":"Benn DE et al. (2005) Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab 91: 790\u2013792","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0396_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1196\/annals.1353.003","volume":"1073","author":"M Barontini","year":"2006","unstructured":"Barontini M et al. (2006) Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann NY Acad Sci 1073: 30\u201337","journal-title":"Ann NY Acad Sci"},{"key":"BFncpendmet0396_CR43","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1385\/EP:14:4:375","volume":"14","author":"A Weinhausel","year":"2003","unstructured":"Weinhausel A et al. (2003) Long-term follow up of a \u201csporadic\u201d unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman. Endocr Pathol 14: 375\u2013382","journal-title":"Endocr Pathol"},{"key":"BFncpendmet0396_CR44","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1046\/j.1365-2265.2003.01914.x","volume":"59","author":"D Astuti","year":"2003","unstructured":"Astuti D et al. (2003) Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clin Endocrinol (Oxf) 59: 728\u2013733","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0396_CR45","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1056\/NEJM199906173402404","volume":"340","author":"G Eisenhofer","year":"1999","unstructured":"Eisenhofer G et al. (1999) Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340: 1872\u20131879","journal-title":"N Engl J Med"},{"key":"BFncpendmet0396_CR46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1210\/er.2002-0013","volume":"24","author":"EL Bravo","year":"2003","unstructured":"Bravo EL and Tagle R (2003) Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 24: 539\u2013553","journal-title":"Endocr Rev"},{"key":"BFncpendmet0396_CR47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1053\/jcan.2002.124150","volume":"16","author":"MA Kinney","year":"2002","unstructured":"Kinney MA et al. (2002) Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 16: 359\u2013369","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"BFncpendmet0396_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","volume":"134","author":"K Pacak","year":"2001","unstructured":"Pacak K et al. (2001) Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 134: 315\u2013329","journal-title":"Ann Intern Med"},{"key":"BFncpendmet0396_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/bja\/85.1.44","volume":"85","author":"C Prys-Roberts","year":"2000","unstructured":"Prys-Roberts C (2000) Phaeochromocytoma\u2014recent progress in its management. Br J Anaesth 85: 44\u201357","journal-title":"Br J Anaesth"},{"key":"BFncpendmet0396_CR50","first-page":"1149","volume":"106","author":"C Proye","year":"1989","unstructured":"Proye C et al. (1989) Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. Surgery 106: 1149\u20131154","journal-title":"Surgery"},{"key":"BFncpendmet0396_CR51","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1161\/01.HYP.29.5.1133","volume":"29","author":"PF Plouin","year":"1997","unstructured":"Plouin PF et al. (1997) Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension 29: 1133\u20131139","journal-title":"Hypertension"},{"key":"BFncpendmet0396_CR52","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0022-5347(01)62886-6","volume":"160","author":"G Janetschek","year":"1998","unstructured":"Janetschek G et al. (1998) Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. J Urol 160: 330\u2013334","journal-title":"J Urol"},{"key":"BFncpendmet0396_CR53","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/00000658-200205000-00014","volume":"235","author":"LM Brunt","year":"2002","unstructured":"Brunt LM et al. (2002) Adrenalectomy for familial pheochromocytoma in the laparoscopic era. Ann Surg 235: 713\u2013720","journal-title":"Ann Surg"},{"key":"BFncpendmet0396_CR54","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0039-6060(96)80056-0","volume":"120","author":"J Lee","year":"1996","unstructured":"Lee J et al. (1996) Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 120: 1064\u20131070","journal-title":"Surgery"},{"key":"BFncpendmet0396_CR55","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.eururo.2005.01.006","volume":"47","author":"T Nambirajan","year":"2005","unstructured":"Nambirajan T et al. (2005) Laparoscopic adrenal surgery for recurrent tumours in patients with hereditary phaeochromocytoma. Eur Urol 47: 622\u2013626","journal-title":"Eur Urol"},{"key":"BFncpendmet0396_CR56","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jamcollsurg.2003.12.001","volume":"198","author":"L Yip","year":"2004","unstructured":"Yip L et al. (2004) Surgical management of hereditary pheochromocytoma. J Am Coll Surg 198: 525\u2013534","journal-title":"J Am Coll Surg"},{"key":"BFncpendmet0396_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1385\/EP:13:1:17","volume":"13","author":"CA Koch","year":"2002","unstructured":"Koch CA et al. (2002) Pheochromocytoma in von Hippel-Lindau disease: Distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2. Endocr Pathol 13: 17\u201327","journal-title":"Endocr Pathol"},{"key":"BFncpendmet0396_CR58","volume-title":"Tumours of Endocrine Organs","author":"RA DeLellis","year":"2004","unstructured":"DeLellis RA et al. (Eds; 2004) Tumours of Endocrine Organs. Lyon: IARC Press"},{"key":"BFncpendmet0396_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1385\/EP:16:1:023","volume":"16","author":"N Kimura","year":"2005","unstructured":"Kimura N et al. (2005) Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 16: 23\u201332","journal-title":"Endocr Pathol"},{"key":"BFncpendmet0396_CR60","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/0046-8177(90)90155-X","volume":"21","author":"RI Linnoila","year":"1990","unstructured":"Linnoila RI et al. (1990) Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 21: 1168\u20131180","journal-title":"Hum Pathol"},{"key":"BFncpendmet0396_CR61","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","volume":"26","author":"LD Thompson","year":"2002","unstructured":"Thompson LD (2002) Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26: 551\u2013566","journal-title":"Am J Surg Pathol"},{"key":"BFncpendmet0396_CR62","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/hupa.2003.13","volume":"34","author":"EE Lack","year":"2003","unstructured":"Lack EE et al. (2003) Recommendations for the reporting of extra-adrenal paragangliomas. The Association of Directors of Anatomic and Surgical Pathology. Hum Pathol 34: 112\u2013113","journal-title":"Hum Pathol"},{"key":"BFncpendmet0396_CR63","unstructured":"Association of Directors of Anatomic and Surgical Pathology [ http:\/\/www.adasp.org ] (accessed 15 September 2006)"},{"key":"BFncpendmet0396_CR64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s004280050403","volume":"435","author":"EE Lack","year":"1999","unstructured":"Lack EE (1999) Recommendations for the reporting of tumors of the adrenal cortex and medulla. Association of Directors of Anatomic and Surgical Pathology. Virchows Arch 435: 87\u201391","journal-title":"Virchows Arch"},{"key":"BFncpendmet0396_CR65","unstructured":"The Royal College of Pathologists [ http:\/\/www.rcpath.org ] (accessed 15 September 2006)"},{"key":"BFncpendmet0396_CR66","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1677\/erc.1.00829","volume":"11","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer G et al. (2004) Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 11: 423\u2013436","journal-title":"Endocr Relat Cancer"},{"key":"BFncpendmet0396_CR67","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/modpathol.3800160","volume":"17","author":"C August","year":"2004","unstructured":"August C et al. (2004) CGH and CD 44\/MIB-1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas. Mod Pathol 17: 1119\u20131128","journal-title":"Mod Pathol"},{"key":"BFncpendmet0396_CR68","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","volume":"229","author":"RE Goldstein","year":"1999","unstructured":"Goldstein RE et al. (1999) Clinical experience over 48 years with pheochromocytoma. Ann Surg 229: 755\u2013764","journal-title":"Ann Surg"},{"key":"BFncpendmet0396_CR69","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0090-4295(98)00612-8","volume":"53","author":"H John","year":"1999","unstructured":"John H et al. (1999) Pheochromocytomas: can malignant potential be predicted? Urology 53: 679\u2013683","journal-title":"Urology"},{"key":"BFncpendmet0396_CR70","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/BF00353738","volume":"18","author":"CA Proye","year":"1994","unstructured":"Proye CA et al. (1994) \u201cThe\u201d pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist? World J Surg 18: 467\u2013472","journal-title":"World J Surg"},{"key":"BFncpendmet0396_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-5347(17)37119-7","volume":"147","author":"RK Whalen","year":"1992","unstructured":"Whalen RK et al. (1992) Extra-adrenal pheochromocytoma. J Urol 147: 1\u201310","journal-title":"J Urol"},{"key":"BFncpendmet0396_CR72","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1055\/s-0029-1212001","volume":"106","author":"J Mundschenk","year":"1998","unstructured":"Mundschenk J and Lehnert H (1998) Malignant pheochromocytoma. Exp Clin Endocrinol Diabetes 106: 373\u2013376","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"BFncpendmet0396_CR73","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1677\/erc.1.00913","volume":"12","author":"FM Brouwers","year":"2005","unstructured":"Brouwers FM et al. (2005) Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. Endocr Relat Cancer 12: 263\u2013272","journal-title":"Endocr Relat Cancer"},{"key":"BFncpendmet0396_CR74","doi-asserted-by":"publisher","first-page":"267","DOI":"10.7326\/0003-4819-109-4-267","volume":"109","author":"SD Averbuch","year":"1988","unstructured":"Averbuch SD et al. (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 109: 267\u2013273","journal-title":"Ann Intern Med"},{"key":"BFncpendmet0396_CR75","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/cncr.11518","volume":"98","author":"B Rose","year":"2003","unstructured":"Rose B et al. (2003) High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer 98: 239\u2013248","journal-title":"Cancer"},{"key":"BFncpendmet0396_CR76","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0039-6060(03)00426-4","volume":"134","author":"SD Safford","year":"2003","unstructured":"Safford SD et al. (2003) Iodine-131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery 134: 956\u2013962","journal-title":"Surgery"},{"key":"BFncpendmet0396_CR77","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2169\/internalmedicine.38.349","volume":"38","author":"K Takahashi","year":"1999","unstructured":"Takahashi K et al. (1999) Malignant pheochromocytoma with multiple hepatic metastases treated by chemotherapy and transcatheter arterial embolization. Intern Med 38: 349\u2013354","journal-title":"Intern Med"},{"key":"BFncpendmet0396_CR78","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/BF03348026","volume":"20","author":"KC Loh","year":"1997","unstructured":"Loh KC et al. (1997) The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 20: 648\u2013658","journal-title":"J Endocrinol Invest"},{"key":"BFncpendmet0396_CR79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1046\/j.1365-2265.2001.01309.x","volume":"55","author":"JJ Mukherjee","year":"2001","unstructured":"Mukherjee JJ et al. (2001) Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG]. Clin Endocrinol (Oxf) 55: 47\u201360","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0396_CR80","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/1097-0231(20001115)14:21<1959::AID-RCM117>3.0.CO;2-T","volume":"14","author":"EC Chan","year":"2000","unstructured":"Chan EC and Ho PC (2000) High-performance liquid chromatography\/atmospheric pressure chemical ionization mass spectrometric method for the analysis of catecholamines and metanephrines in human urine. Rapid Commun Mass Spectrom 14: 1959\u20131964","journal-title":"Rapid Commun Mass Spectrom"},{"key":"BFncpendmet0396_CR81","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/clinchem\/48.2.332","volume":"48","author":"DK Crockett","year":"2002","unstructured":"Crockett DK et al. (2002) Rapid analysis of metanephrine and normetanephrine in urine by gas chromatography-mass spectrometry. Clin Chem 48: 332\u2013337","journal-title":"Clin Chem"},{"key":"BFncpendmet0396_CR82","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1373\/clinchem.2003.024703","volume":"50","author":"SA Lagerstedt","year":"2004","unstructured":"Lagerstedt SA et al. (2004) Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma. Clin Chem 50: 603\u2013611","journal-title":"Clin Chem"},{"key":"BFncpendmet0396_CR83","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/clinchem\/48.3.533","volume":"48","author":"RL Taylor","year":"2002","unstructured":"Taylor RL and Singh RJ (2002) Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. Clin Chem 48: 533\u2013539","journal-title":"Clin Chem"}],"container-title":["Nature Clinical Practice Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0396","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:51:42Z","timestamp":1684439502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["BFncpendmet0396"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0396","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}